HIGHLIGHTS
- who: Farokh Dotiwala from the Medical University of Vienna, Austria have published the article: A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects, in the Journal: (JOURNAL) of July/26,/2022
- what: BBV152 is an exciting player in the Anti-SARS-CoV-2 vaccination landscape.
- how: A similar study was conducted in New York state to assess the effectiveness of the BNT162b2 (Pfizer) mRNA-1273 (Moderna) and Ad26.COV2.S (Johnson and amp Johnson) vaccines .
- future: While some studies report improvements in vaccine efficacy by heterologous prime-boost . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.